Fresenius Medical Care (FMEA) Ratios
Fresenius Medical Care Ratios
DE:FMEA's free cash flow for Q2 2026 was $619.90M. For the 2026 fiscal year, DE:FMEA's free cash flow was decreased by $-240.40M and operating cash flow was $860.30M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.26 | 1.40 | 1.42 | 1.27 | 1.10 |
| Quick Ratio | 0.92 | 1.03 | 1.07 | 0.91 | 0.82 |
| Cash Ratio | 0.26 | 0.21 | 0.23 | 0.20 | 0.20 |
| Solvency Ratio | 0.15 | 0.13 | 0.12 | 0.12 | 0.13 |
| Operating Cash Flow Ratio | 0.41 | 0.42 | 0.43 | 0.34 | 0.34 |
| Short-Term Operating Cash Flow Coverage | 1.60 | 4.13 | 2.78 | 1.61 | 1.29 |
| Net Current Asset Value | $ -8.82B | $ -9.88B | $ -10.40B | $ -12.10B | $ -12.42B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.35 | 0.33 | 0.36 | 0.37 | 0.39 |
| Debt-to-Equity Ratio | 0.76 | 0.75 | 0.89 | 0.94 | 1.05 |
| Debt-to-Capital Ratio | 0.43 | 0.43 | 0.47 | 0.49 | 0.51 |
| Long-Term Debt-to-Capital Ratio | 0.28 | 0.30 | 0.34 | 0.34 | 0.34 |
| Financial Leverage Ratio | 2.17 | 2.30 | 2.49 | 2.56 | 2.71 |
| Debt Service Coverage Ratio | 1.54 | 2.94 | 2.12 | 1.82 | 1.40 |
| Interest Coverage Ratio | 4.75 | 3.60 | 3.22 | 4.20 | 5.24 |
| Debt to Market Cap | 0.62 | 0.53 | 0.70 | 0.48 | 0.26 |
| Interest Debt Per Share | 19.20 | 19.41 | 21.30 | 11.57 | 11.67 |
| Net Debt to EBITDA | 2.71 | 3.06 | 3.33 | 3.49 | 3.34 |
| Profitability Margins | |||||
| Gross Profit Margin | 25.62% | 24.60% | 25.32% | 25.23% | 27.09% |
| EBIT Margin | 9.66% | 7.57% | 7.49% | 8.14% | 10.93% |
| EBITDA Margin | 17.31% | 16.58% | 16.50% | 17.62% | 20.14% |
| Operating Profit Margin | 9.31% | 7.59% | 7.04% | 7.79% | 10.51% |
| Pretax Profit Margin | 7.70% | 5.47% | 5.31% | 6.29% | 8.92% |
| Net Profit Margin | 4.98% | 2.78% | 2.57% | 3.47% | 5.50% |
| Continuous Operations Profit Margin | 6.07% | 3.83% | 3.77% | 4.61% | 6.92% |
| Net Income Per EBT | 64.70% | 50.89% | 48.30% | 55.23% | 61.67% |
| EBT Per EBIT | 82.78% | 72.03% | 75.43% | 80.65% | 84.86% |
| Return on Assets (ROA) | 3.16% | 1.60% | 1.47% | 1.88% | 2.82% |
| Return on Equity (ROE) | 6.85% | 3.69% | 3.66% | 4.81% | 7.63% |
| Return on Capital Employed (ROCE) | 7.38% | 5.26% | 4.92% | 5.16% | 6.83% |
| Return on Invested Capital (ROIC) | 5.34% | 3.53% | 3.30% | 3.54% | 4.84% |
| Return on Tangible Assets | 6.05% | 3.16% | 2.78% | 3.65% | 5.23% |
| Earnings Yield | 8.29% | 4.19% | 4.42% | 3.76% | 2.90% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.25 | 5.67 | 5.35 | 5.21 | 4.92 |
| Payables Turnover | 19.78 | 14.81 | 16.41 | 15.24 | 14.98 |
| Inventory Turnover | 6.82 | 7.05 | 6.67 | 6.32 | 6.30 |
| Fixed Asset Turnover | 6.51 | 2.66 | 2.61 | 2.33 | 2.06 |
| Asset Turnover | 0.63 | 0.58 | 0.57 | 0.54 | 0.51 |
| Working Capital Turnover Ratio | 10.03 | 7.97 | 8.99 | 15.86 | 18.27 |
| Cash Conversion Cycle | 93.51 | 91.48 | 100.77 | 103.83 | 107.72 |
| Days of Sales Outstanding | 58.43 | 64.35 | 68.26 | 69.99 | 74.17 |
| Days of Inventory Outstanding | 53.53 | 51.77 | 54.75 | 57.78 | 57.91 |
| Days of Payables Outstanding | 18.45 | 24.64 | 22.24 | 23.95 | 24.37 |
| Operating Cycle | 111.96 | 116.12 | 123.01 | 127.78 | 132.08 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 4.42 | 4.06 | 4.48 | 1.85 | 2.12 |
| Free Cash Flow Per Share | 2.91 | 2.87 | 3.31 | 1.23 | 1.40 |
| Dividend Paid and CapEx Coverage Ratio | 2.00 | 2.28 | 2.59 | 1.94 | 2.00 |
| Capital Expenditure Coverage Ratio | 2.93 | 3.41 | 3.84 | 2.99 | 2.91 |
| Operating Cash Flow Coverage Ratio | 0.24 | 0.22 | 0.22 | 0.16 | 0.19 |
| Operating Cash Flow to Sales Ratio | 0.13 | 0.12 | 0.14 | 0.11 | 0.14 |
| Free Cash Flow Yield | 14.36% | 13.12% | 17.23% | 8.06% | 4.89% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.07 | 23.89 | 22.62 | 26.58 | 34.51 |
| Price-to-Sales (P/S) Ratio | 0.60 | 0.66 | 0.58 | 0.92 | 1.90 |
| Price-to-Book (P/B) Ratio | 0.83 | 0.88 | 0.83 | 1.28 | 2.63 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 6.96 | 7.62 | 5.80 | 12.40 | 20.46 |
| Price-to-Operating Cash Flow Ratio | 4.58 | 5.39 | 4.29 | 8.26 | 13.44 |
| Price-to-Earnings Growth (PEG) Ratio | 0.14 | 3.12 | 0.47 | -0.87 | -0.94 |
| Enterprise Value Multiple | 6.18 | 7.07 | 6.84 | 8.73 | 12.76 |
| Enterprise Value | 21.00B | 22.68B | 21.96B | 29.84B | 45.29B |
| EV to EBITDA | 6.18 | 7.07 | 6.84 | 8.73 | 12.76 |
| EV to Sales | 1.07 | 1.17 | 1.13 | 1.54 | 2.57 |
| EV to Free Cash Flow | 12.38 | 13.44 | 11.30 | 20.67 | 27.70 |
| EV to Operating Cash Flow | 8.16 | 9.50 | 8.35 | 13.77 | 18.19 |
| Tangible Book Value Per Share | -0.93 | -1.31 | -2.02 | -1.59 | -1.57 |
| Shareholders’ Equity Per Share | 24.53 | 24.79 | 23.20 | 11.93 | 10.84 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.30 | 0.29 | 0.27 | 0.22 |
| Revenue Per Share | 33.70 | 32.89 | 33.14 | 16.54 | 15.04 |
| Net Income Per Share | 1.68 | 0.91 | 0.85 | 0.57 | 0.83 |
| Tax Burden | 0.65 | 0.51 | 0.48 | 0.55 | 0.62 |
| Interest Burden | 0.80 | 0.72 | 0.71 | 0.77 | 0.82 |
| Research & Development to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| SG&A to Revenue | 0.15 | 0.16 | 0.12 | 0.12 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.74 | 3.22 | 3.59 | 2.42 | 2.04 |
Currency in EUR
